These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37406934)
21. [Rapid detection and genotyping of SARS-CoV-2 Omicron BA.4/5 variants using a RT-PCR and CRISPR-Cas12a-based assay]. Ma Y; Zou L; Liang Y; Liu Q; Sun Q; Pang Y; Lin H; Deng X; Tang S Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):516-526. PubMed ID: 37202186 [TBL] [Abstract][Full Text] [Related]
22. Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021. Subramoney K; Mtileni N; Bharuthram A; Davis A; Kalenga B; Rikhotso M; Maphahlele M; Giandhari J; Naidoo Y; Pillay S; Ramphal U; Ramphal Y; Tegally H; Wilkinson E; Mohale T; Ismail A; Mashishi B; Mbenenge N; de Oliveira T; Makatini Z; Fielding BC; Treurnicht FK; J Med Virol; 2022 Aug; 94(8):3676-3684. PubMed ID: 35441368 [TBL] [Abstract][Full Text] [Related]
23. Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR. Yolshin ND; Komissarov AB; Varchenko KV; Musaeva TD; Fadeev AV; Lioznov DA Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555794 [TBL] [Abstract][Full Text] [Related]
24. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread. Parums DV Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047 [TBL] [Abstract][Full Text] [Related]
25. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023. Ma KC; Shirk P; Lambrou AS; Hassell N; Zheng XY; Payne AB; Ali AR; Batra D; Caravas J; Chau R; Cook PW; Howard D; Kovacs NA; Lacek KA; Lee JS; MacCannell DR; Malapati L; Mathew S; Mittal N; Nagilla RR; Parikh R; Paul P; Rambo-Martin BL; Shepard SS; Sheth M; Wentworth DE; Winn A; Hall AJ; Silk BJ; Thornburg N; Kondor R; Scobie HM; Paden CR MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):651-656. PubMed ID: 37319011 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022. Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430 [TBL] [Abstract][Full Text] [Related]
27. Laboratory-Confirmed COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance - COVID-19-Associated Hospitalization Surveillance Network, 14 States, June 20, 2021-May 31, 2022. Havers FP; Patel K; Whitaker M; Milucky J; Reingold A; Armistead I; Meek J; Anderson EJ; Weigel A; Reeg L; Seys S; Ropp SL; Spina N; Felsen CB; Moran NE; Sutton M; Talbot HK; George A; Taylor CA; MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(34):1085-1091. PubMed ID: 36006841 [TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022. Hirotsu Y; Maejima M; Shibusawa M; Natori Y; Nagakubo Y; Hosaka K; Sueki H; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M J Infect; 2022 Aug; 85(2):174-211. PubMed ID: 35490739 [No Abstract] [Full Text] [Related]
29. SARS-CoV-2 variants of concern surveillance including Omicron using RT-PCR-based genotyping offers comparable performance to whole genome sequencing. Vanoni S; Matulevicius A; Avdiu B; Scantamburlo G; Ulekleiv C; Brzoska PM; Furtado MR; Feenstra JDM; Rico A; Gandhi M; Giacobazzi E; Masi E; Paulmichl M; Nofziger C Front Cell Infect Microbiol; 2022; 12():960065. PubMed ID: 36405967 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. Link-Gelles R; Levy ME; Gaglani M; Irving SA; Stockwell M; Dascomb K; DeSilva MB; Reese SE; Liao IC; Ong TC; Grannis SJ; McEvoy C; Patel P; Klein NP; Hartmann E; Stenehjem E; Natarajan K; Naleway AL; Murthy K; Rao S; Dixon BE; Kharbanda AB; Akinseye A; Dickerson M; Lewis N; Grisel N; Han J; Barron MA; Fadel WF; Dunne MM; Goddard K; Arndorfer J; Konatham D; Valvi NR; Currey JC; Fireman B; Raiyani C; Zerbo O; Sloan-Aagard C; Ball SW; Thompson MG; Tenforde MW MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(29):931-939. PubMed ID: 35862287 [TBL] [Abstract][Full Text] [Related]
32. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022. Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225 [TBL] [Abstract][Full Text] [Related]
33. The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution. Veneziano C; Marascio N; De Marco C; Quaresima B; Biamonte F; Trecarichi EM; Santamaria G; Quirino A; Torella D; Quattrone A; Matera G; Torti C; De Filippo C; Costanzo FS; Viglietto G Viruses; 2023 Jan; 15(2):. PubMed ID: 36851622 [TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022. Fonager J; Bennedbæk M; Bager P; Wohlfahrt J; Ellegaard KM; Ingham AC; Edslev SM; Stegger M; Sieber RN; Lassauniere R; Fomsgaard A; Lillebaek T; Svarrer CW; Møller FT; Møller CH; Legarth R; Sydenham TV; Steinke K; Paulsen SJ; Castruita JAS; Schneider UV; Schouw CH; Nielsen XC; Overvad M; Nielsen RT; Marvig RL; Pedersen MS; Nielsen L; Nilsson LL; Bybjerg-Grauholm J; Tarpgaard IH; Ebsen TS; Lam JUH; Gunalan V; Rasmussen M Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272746 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506 [TBL] [Abstract][Full Text] [Related]
36. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking. Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776 [TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California. Lewnard JA; Hong VX; Patel MM; Kahn R; Lipsitch M; Tartof SY Nat Med; 2022 Sep; 28(9):1933-1943. PubMed ID: 35675841 [TBL] [Abstract][Full Text] [Related]
38. Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022. Stefanelli P; Trentini F; Petrone D; Mammone A; Ambrosio L; Manica M; Guzzetta G; d'Andrea V; Marziano V; Zardini A; Molina Grane' C; Ajelli M; Di Martino A; Riccardo F; Bella A; Sane Schepisi M; Maraglino F; Poletti P; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Merler S; ; ; ; Euro Surveill; 2022 Nov; 27(45):. PubMed ID: 36367013 [TBL] [Abstract][Full Text] [Related]
39. Occurrence of the Omicron variant of SARS-CoV-2 in northern Viet Nam in early 2022. Ung TTH; Hoang PVM; Nguyen SV; Nguyen HLK; Nguyen PTK; Phan DT; Le TT; Nguyen AP; ; Hasebe F; Le MTQ Western Pac Surveill Response J; 2022; 13(3):1-5. PubMed ID: 36688184 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China. Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]